The European Medicines Agency (EMA) made the announcement on 28 October 2022.
The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) ‘recommended that heavy menstrual bleeding should be added to the product information as a side effect of unknown frequency of the mRNA COVID-19 vaccines Comirnaty and Spikevax.’
A statement on the EMA’s website said:
Heavy menstrual bleeding (heavy periods) may be defined as bleeding characterised by an increased volume and/or duration which interferes with the person’s physical, social, emotional and material quality of life. Cases of heavy menstrual bleeding have been reported after the first, second and booster doses of Comirnaty and Spikevax.
The PRAC finalised the assessment of this safety signal after reviewing the available data, including cases reported during clinical trials, cases spontaneously reported in Eudravigilance and findings from the medical literature.
After reviewing the data, the Committee concluded that there is at least a reasonable possibility that the occurrence of heavy menstrual bleeding is causally associated with these vaccines and therefore recommended the update of the product information.
However, EMA went on to say there was ‘no evidence to suggest the menstrual disorders experienced by some people have any impact on reproduction and fertility’, and that ‘use of mRNA COVID-19 vaccines before and during pregnancy’ was safe.
This advice contradicts evidence of some midwives and funeral directors who say they have seen a marked increase in stillborn births since the jab roll-outs.
As of today, the Ministry of Health website does not include heavy menstrual bleeding as a side effect of the mRNA injections in New Zealand.
Image credit: NEOSiAM 2021
System pigs in NZ will get ready to create NZ data supporting full safety of the jabs. A small decline in heavy periods has actually the case with NZ women as per the STUBB propaganda mercenaries. Public interest journalism you know. Long live the Supreme Leader.????????????